NPCE

Neuropace, Inc.

8.32 USD
+0.15 (+1.84%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Neuropace, Inc. stock is down -40.57% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 3 May’s closed higher than April. In the last 3 Unusual Options Trades, there were 3 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
25 Mar 14:44 19 Apr, 2024 12.50 CALL 250 3
05 Apr 18:19 17 May, 2024 12.50 CALL 99 100
08 Apr 14:57 16 Aug, 2024 12.50 CALL 189 202

About Neuropace, Inc.

NeuroPace, Inc. develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company was incorporated in 1997 and is headquartered in Mountain View, California.